{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:10:20Z","timestamp":1790799020620,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.blre.2005.02.002","type":"journal-article","created":{"date-parts":[[2005,4,4]],"date-time":"2005-04-04T13:29:06Z","timestamp":1112621346000},"page":"83-92","source":"Crossref","is-referenced-by-count":27,"title":["Oligosaccharide structures of von Willebrand factor and their potential role in von Willebrand disease"],"prefix":"10.1016","volume":"20","author":[{"given":"Carolyn M.","family":"Millar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2005.02.002_bib1","first-page":"7","article-title":"Hereditar pseudohemofili","volume":"67","author":"Von Willebrand","year":"1926","journal-title":"Fin Lakaresallsk Handl"},{"key":"10.1016\/j.blre.2005.02.002_bib2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1182\/blood.V84.3.676.676","article-title":"Commentary: a new classification for von Willebrand disease","volume":"84","author":"Sadler","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.02.002_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V54.1.117.117","article-title":"Genetics of classic von Willebrand\u2019s disease. I. Phenotypic variation within families","volume":"54","author":"Miller","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.02.002_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/blood.V54.1.137.137","article-title":"Genetics of classic von Willebrand\u2019s disease. II. Optimal assignment of the heterozygous genotype (diagnosis) by discriminant analysis","volume":"54","author":"Miller","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.02.002_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s005990050054","article-title":"The molecular basis of von Willebrand disease","volume":"29","author":"Mohlke","year":"1999","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.blre.2005.02.002_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02981973","article-title":"Molecular genetics of type 2 von Willebrand disease","volume":"75","author":"Fressinaud","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2005.02.002_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1055\/s-0037-1614063","article-title":"Molecular characterization of a multiethnic group of 21 patients with type 3 von Willebrand disease","volume":"84","author":"Baronciani","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2005.02.002_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2141.2001.03132.x","article-title":"Significant linkage and non-linkage of type 1 von Willebrand disease to the von Willebrand factor gene","volume":"115","author":"Casana","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2005.02.002_bib9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1055\/s-0037-1614330","article-title":"Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation","volume":"82","author":"Castaman","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2005.02.002_bib10","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood.V79.10.2507.bloodjournal79102507","article-title":"Molecular genetics of von Willebrand disease","volume":"79","author":"Ginsburg","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.02.002_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0037-1614927","article-title":"Factor VIII and von Willebrand factor","volume":"79","author":"Vlot","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2005.02.002_bib12","doi-asserted-by":"crossref","first-page":"8723","DOI":"10.1016\/S0021-9258(19)50338-6","article-title":"Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures","volume":"267","author":"Matsui","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2005.02.002_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/glycob\/3.2.97","article-title":"Biological roles of oligosaccharides: all of the theories are correct","volume":"3","author":"Varki","year":"1993","journal-title":"Glycobiology"},{"key":"10.1016\/j.blre.2005.02.002_bib14","doi-asserted-by":"crossref","first-page":"10754","DOI":"10.1016\/S0021-9258(19)86586-9","article-title":"Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human Factor VIII\/von Willebrand factor","volume":"254","author":"Sodetz","year":"1979","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2005.02.002_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0092-8674(00)80964-2","article-title":"Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase","volume":"96","author":"Mohlke","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.blre.2005.02.002_bib16","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI107471","article-title":"Synthesis of antihemophilic factor antigen by cultured human endothelial cells","volume":"52","author":"Jaffe","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2005.02.002_bib17","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1172\/JCI108846","article-title":"Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes","volume":"60","author":"Nachman","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2005.02.002_bib18","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1083\/jcb.99.6.2123","article-title":"Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization","volume":"99","author":"Wagner","year":"1984","journal-title":"J Cell Biol"},{"key":"10.1016\/j.blre.2005.02.002_bib19","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1021\/bi00359a015","article-title":"Amino acid sequence of human von Willebrand factor","volume":"25","author":"Titani","year":"1986","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.blre.2005.02.002_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0092-8674(91)90648-I","article-title":"Induction of specific storage organelles by von Willebrand factor propolypeptide","volume":"64","author":"Wagner","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.blre.2005.02.002_bib21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1096\/fasebj.7.2.8440408","article-title":"von Willebrand factor","volume":"7","author":"Ruggeri","year":"1993","journal-title":"FASEB J"},{"key":"10.1016\/j.blre.2005.02.002_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0049-3848(82)90216-X","article-title":"Preliminary results on the carbohydrate moiety of factor VIII\/von Willebrand factor (FVIII\/vWf)","volume":"25","author":"Samor","year":"1982","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2005.02.002_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0014-5793(83)80334-2","article-title":"Structure determination of the major asparagine-linked sugar chain of human factor VIII\u2013von Willebrand factor","volume":"151","author":"Debeire","year":"1983","journal-title":"FEBS Lett"},{"key":"10.1016\/j.blre.2005.02.002_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1432-1033.1982.tb05803.x","article-title":"Primary structure of the glycans from human lactotransferrin","volume":"121","author":"Spik","year":"1982","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.blre.2005.02.002_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1432-1033.1982.tb06694.x","article-title":"Primary structure of the N-glycosidically linked sialoglycans of secretory immunoglobulins A from human milk","volume":"125","author":"Pierce-Cretel","year":"1982","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.blre.2005.02.002_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1432-1033.1986.tb09750.x","article-title":"Primary structure of a new tetraantennary glycan of the N-acetyllactosaminic type isolated from human factor VIII\/von Willebrand factor","volume":"158","author":"Samor","year":"1986","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.blre.2005.02.002_bib27","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1182\/blood.V94.8.2895.420a03_2895_2900","article-title":"ABO blood group antigens on human plasma von Willebrand factor after ABO-mismatched bone marrow transplantation","volume":"94","author":"Matsui","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.02.002_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF01047846","article-title":"Primary structure of the major O-glycosidically linked carbohydrate unit of human von Willebrand factor","volume":"6","author":"Samor","year":"1989","journal-title":"Glycoconj J"},{"key":"10.1016\/j.blre.2005.02.002_bib29","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0006-291X(91)91028-B","article-title":"Carbohydrate analysis of human von Willebrand factor with horseradish peroxidase-conjugated lectins","volume":"178","author":"Matsui","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.blre.2005.02.002_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.bi.56.070187.000321","article-title":"Fractionation and structural assessment of oligosaccharides and glycopeptides by use of immobilized lectins","volume":"56","author":"Osawa","year":"1987","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.blre.2005.02.002_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.1083071","article-title":"Carbohydrate deficiency of the factor VIII\/von Willebrand factor Protein in von Willebrand\u2019s disease variants","volume":"192","author":"Gralnick","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.blre.2005.02.002_bib32","doi-asserted-by":"crossref","first-page":"10042","DOI":"10.1073\/pnas.142005099","article-title":"Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands","volume":"99","author":"Ellies","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2005.02.002_bib33","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1056\/NEJM197705052961802","article-title":"Von Willebrand\u2019s disease: combined qualitative and quantitative abnormalities","volume":"296","author":"Gralnick","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2005.02.002_bib34","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI109585","article-title":"Carbohydrate of the factor VIII\/von Willebrand factor in von Willebrand\u2019s disease","volume":"64","author":"Zimmerman","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2005.02.002_bib35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1172\/JCI110259","article-title":"Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent","volume":"68","author":"De Marco","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2005.02.002_bib36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2141.1974.tb00507.x","article-title":"Platelet-aggregating activity in neuraminidase-treated human cryoprecipitates: its correlation with factor-VIII-related antigen","volume":"26","author":"Vermylen","year":"1974","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2005.02.002_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/244167a0","article-title":"Aggregation of human platelets by bovine or human factor VIII: role of carbohydrate side chains","volume":"244","author":"Vermylen","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.blre.2005.02.002_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0049-3848(79)90071-9","article-title":"The effects of neuraminidase treatment on the biological activities of factor VIII","volume":"15","author":"Rosenfeld","year":"1979","journal-title":"Thromb Res"},{"issue":"Suppl","key":"10.1016\/j.blre.2005.02.002_bib39","first-page":"60","article-title":"Dissociation between human platelet agglomerating activity and factor VIII procoagulant activity of bovine plasma preparations by chemical treatment. I. Effect of neuraminidase","volume":"21","author":"Levy-Toledano","year":"1973","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.blre.2005.02.002_bib40","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1016\/S0021-9258(19)63384-3","article-title":"Relationship of sialic acid to function and in vivo survival of human factor VIII\/von Willebrand factor protein","volume":"252","author":"Sodetz","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2005.02.002_bib41","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1016\/S0021-9258(17)34484-8","article-title":"Carbohydrate on human factor VIII\/von Willebrand factor. Impairment of function by removal of specific galactose residues","volume":"253","author":"Sodetz","year":"1978","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2005.02.002_bib42","doi-asserted-by":"crossref","first-page":"10134","DOI":"10.1016\/S0021-9258(19)70438-4","article-title":"Factor VIII\/von Willebrand protein. Modification of its carbohydrate causes reduced binding to platelets","volume":"255","author":"Kao","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2005.02.002_bib43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2141.1977.tb00647.x","article-title":"Studies of von Willebrand factor: effects of different kinds of carbohydrate oxidases, SH-inhibitors and some other chemical reagents","volume":"36","author":"Fukui","year":"1977","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2005.02.002_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood.V55.1.9.9","article-title":"Selective binding of the factor VIII\/von Willebrand factor protein to human platelets","volume":"55","author":"Morisato","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.02.002_bib45","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1172\/JCI109152","article-title":"Factor VIII\/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity","volume":"62","author":"Gralnick","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2005.02.002_bib46","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-0038-1661321","article-title":"Effect of carbohydrate modifications of factor VIII\/von Willebrand factor on binding to platelets","volume":"53","author":"Goudemand","year":"1985","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2005.02.002_bib47","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1073\/pnas.80.9.2771","article-title":"Role of carbohydrate in multimeric structure of factor VIII\/von Willebrand factor protein","volume":"80","author":"Gralnick","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2005.02.002_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0049-3848(90)90195-I","article-title":"Critical role of the carbohydrate moiety in human von Willebrand factor protein for interactions with type I collagen","volume":"57","author":"Kessler","year":"1990","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2005.02.002_bib49","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1083\/jcb.102.4.1320","article-title":"Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor","volume":"102","author":"Wagner","year":"1986","journal-title":"J Cell Biol"},{"key":"10.1016\/j.blre.2005.02.002_bib50","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1172\/JCI111628","article-title":"Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation","volume":"74","author":"Federici","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2005.02.002_bib51","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1182\/blood.V72.5.1790.1790","article-title":"Sialic acid prevents loss of large von Willebrand factor multimers by protecting against amino-terminal proteolytic cleavage","volume":"72","author":"Berkowitz","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.02.002_bib52","doi-asserted-by":"crossref","first-page":"8549","DOI":"10.1016\/S0021-9258(18)34366-7","article-title":"Carbohydrates selectively protect a specific domain of fibronectin against proteases","volume":"257","author":"Bernard","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2005.02.002_bib53","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.bi.51.070182.002531","article-title":"Carbohydrate-specific receptors of the liver","volume":"51","author":"Ashwell","year":"1982","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.blre.2005.02.002_bib54","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0021-9258(19)76994-4","article-title":"The role of sialic acid in determining the survival of glycoproteins in the circulation","volume":"246","author":"Morell","year":"1971","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2005.02.002_bib55","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0006-291X(71)90069-6","article-title":"Properties of asialo and aglycoprothrombin","volume":"45","author":"Nelsestuen","year":"1971","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.blre.2005.02.002_bib56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood.V45.1.11.11","article-title":"Role of sialic acid in erythrocyte survival","volume":"45","author":"Durocher","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.02.002_bib57","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1210\/jcem-65-4-689","article-title":"Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration","volume":"65","author":"Ain","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.blre.2005.02.002_bib58","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/0006-291X(76)91243-2","article-title":"The existence of a second route for the transfer of certain glycoproteins from the circulation into the liver","volume":"68","author":"Stockert","year":"1976","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.blre.2005.02.002_bib59","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1016\/S0021-9258(17)33053-3","article-title":"Effect of glycosylation on the in vivo circulating half-life of ribonuclease","volume":"251","author":"Baynes","year":"1976","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2005.02.002_bib60","doi-asserted-by":"crossref","first-page":"19502","DOI":"10.1074\/jbc.273.31.19502","article-title":"Mechanism of N-acetylgalactosamine binding to a C-type animal lectin carbohydrate-recognition domain","volume":"273","author":"Kolatkar","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2005.02.002_bib61","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1182\/blood.V88.5.1692.1692","article-title":"Clearance of normal and type 2A von Willebrand factor in the rat","volume":"88","author":"Stoddart","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.02.002_bib62","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1182\/blood.V76.11.2258.2258","article-title":"The RIIIS\/J inbred mouse strain as a model for von Willebrand disease","volume":"76","author":"Sweeney","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.02.002_bib63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/geno.1998.5553","article-title":"Comparative mapping of distal murine chromosome 11 and human 17q21.3 in a region containing a modifying locus for murine plasma von Willebrand factor level","volume":"54","author":"Mohlke","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.blre.2005.02.002_bib64","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1182\/blood.V86.6.2461.bloodjournal8662461","article-title":"von Willebrand disease in the RIIIS\/J mouse is caused by a defect outside of the von Willebrand factor gene","volume":"86","author":"Nichols","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.02.002_bib65","first-page":"89","article-title":"Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level","volume":"37","author":"Orstavik","year":"1985","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.blre.2005.02.002_bib66","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.02.002_bib67","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1161\/01.ATV.20.8.2024","article-title":"Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time","volume":"20","author":"Souto","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2005.02.002_bib68","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0950-3536(05)80155-6","article-title":"The blood group-specific human glycosyltransferases","volume":"6","author":"Lowe","year":"1993","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.blre.2005.02.002_bib69","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/hq0202.103997","article-title":"Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels","volume":"22","author":"O\u2019Donnell","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2005.02.002_bib70","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1055\/s-0037-1613123","article-title":"Heterogeneous detection of A-antigen on von Willebrand factor derived from platelets, endothelial cells and plasma","volume":"87","author":"Brown","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2005.02.002_bib71","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0049-3848(92)90097-T","article-title":"Intraplatelet von Willebrand factor and ABO blood group","volume":"68","author":"Sweeney","year":"1992","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2005.02.002_bib72","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1159\/000054087","article-title":"Human umbilical vein endothelial cells differ from other endothelial cells in failing to express ABO blood group antigens","volume":"37","author":"O\u2019Donnell","year":"2000","journal-title":"J Vasc Res"},{"key":"10.1016\/j.blre.2005.02.002_bib73","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-3148.2001.00315.x","article-title":"The relationship between ABO histo-blood group, factor VIII and von Willebrand factor","volume":"11","author":"O\u2019Donnell","year":"2001","journal-title":"Transfus Med"},{"key":"10.1016\/j.blre.2005.02.002_bib74","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1055\/s-0037-1612981","article-title":"The factor VIII\/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor","volume":"87","author":"Eikenboom","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2005.02.002_bib75","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0037-1615135","article-title":"Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease","volume":"80","author":"de Romeuf","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2005.02.002_bib76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2141.2004.05009.x","article-title":"Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease","volume":"126","author":"Mannucci","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2005.02.002_bib77","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1538-7836.2003.00007.x","article-title":"An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13","volume":"1","author":"Bowen","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.blre.2005.02.002_bib78","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0037-1613759","article-title":"The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A","volume":"83","author":"Vlot","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2005.02.002_bib79","first-page":"21","article-title":"Study of VWF antigen clearance in patients with type 1 von Willebrand disease and reporting of a familial tendency (abstract)","volume":"121","author":"Millar","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2005.02.002_bib80","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2141.1981.tb02789.x","article-title":"Response of factor VIII\/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand\u2019s disease","volume":"47","author":"Mannucci","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2005.02.002_bib81","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1046\/j.1538-7836.2003.00359.x","article-title":"Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process","volume":"1","author":"Brown","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2005.02.002_bib82","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2002-27814","article-title":"Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications","volume":"28","author":"Michiels","year":"2002","journal-title":"Semin Thromb Hemost"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X05000202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X05000202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:36:40Z","timestamp":1625704600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X05000202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0268960X05000202"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2005.02.002","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}